Onconic Therapeutics Inc.
Clinical trials sponsored by Onconic Therapeutics Inc., explained in plain language.
-
New drug combo tested to keep ovarian cancer at bay
Disease control Not yet recruitingThis study is testing a new drug combination, JPI-547 with bevacizumab, as a maintenance therapy for women with recurrent ovarian cancer. It aims to see if this combination can help keep the cancer from progressing after patients have responded to platinum-based chemotherapy. The…
Phase: PHASE2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Apr 03, 2026 21:41 UTC
-
New hope for advanced stomach cancer patients who've run out of options
Disease control Not yet recruitingThis study is testing whether a new drug called JPI-547, when combined with an existing chemotherapy drug (irinotecan), is safe and effective for people with advanced stomach cancer that has returned or spread. The trial is for patients who have already tried at least two other t…
Phase: PHASE1, PHASE2 • Sponsor: Onconic Therapeutics Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New heartburn drug enters final testing phase
Symptom relief Not yet recruitingThis study is testing whether a new drug called JP-1366 can safely reduce heartburn and acid reflux symptoms in people with non-erosive GERD, a condition where they experience symptoms but no visible damage in their esophagus. Researchers will measure how many days participants g…
Phase: PHASE3 • Sponsor: Onconic Therapeutics Inc. • Aim: Symptom relief
Last updated Mar 27, 2026 12:39 UTC